0001731122-24-000070.txt : 20240112
0001731122-24-000070.hdr.sgml : 20240112
20240112200046
ACCESSION NUMBER: 0001731122-24-000070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240112
DATE AS OF CHANGE: 20240112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MISSLING CHRISTOPHER U
CENTRAL INDEX KEY: 0001196573
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37606
FILM NUMBER: 24533293
MAIL ADDRESS:
STREET 1: 61 MOULTON ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANAVEX LIFE SCIENCES CORP.
CENTRAL INDEX KEY: 0001314052
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980608404
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 630 5TH AVENUE
STREET 2: 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10111
BUSINESS PHONE: 844-689-3939
MAIL ADDRESS:
STREET 1: 630 5TH AVENUE
STREET 2: 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10111
FORMER COMPANY:
FORMER CONFORMED NAME: Thrifty Printing Inc.
DATE OF NAME CHANGE: 20050111
4
1
ownership.xml
X0508
4
2024-01-02
1
0001314052
ANAVEX LIFE SCIENCES CORP.
AVXL
0001196573
MISSLING CHRISTOPHER U
630 5TH AVENUE,
20TH FLOOR
NEW YORK
NY
10111
1
1
0
0
President and CEO
0
Stock Option (Right to Buy)
10.09
2024-01-02
4
A
0
125000
0
D
2024-01-02
2032-06-27
Common Stock
125000
125000
D
On June 27, 2022, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which included topline data readout of ANAVEX2-73-RS-003 EXCELLENCE clinical trial in Rett Syndrome. The performance criteria for this milestone was met, resulting in vesting of the option as to 125,000 shares.
/s/Christopher Missling
2024-01-12